
Sign up to save your podcasts
Or


Dr Paul Ryan will discuss the use of oral hypoglycaemics & their effect on patients weight. He will also discuss SGLT2s, incretin-based therapies & current diabetes guidelines on cardiovascular outcomes.
By PharmaBuddyDr Paul Ryan will discuss the use of oral hypoglycaemics & their effect on patients weight. He will also discuss SGLT2s, incretin-based therapies & current diabetes guidelines on cardiovascular outcomes.